Connecticut Governor Signs Bill to Give Patients Access to MDMA and Psilocybin Therapy
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Connecticut Governor Ned Lamont signed a budget bill on Monday, May 9th, that included provisions to give patients access to psychedelic-assisted treatments.
Among the bill’s myriad of policy areas, from childcare to environmental protection, the legislation vowed to establish “a psychedelic-assisted therapy pilot program to provide qualified patients with the funding necessary to receive MDMA-assisted or psilocybin-assisted therapy as part of an expanded access program approved by the federal Food and Drug Administration”.
A fund will also be created to issue grants to qualified patients so they can afford the psychedelic-assisted therapy.
As a requirement for treatment, the qualified patients must reside in the state and be either a veteran, a retired first responder or a direct healthcare worker.
The bill also legislates that a new Connecticut Psychedelic Treatment Advisory Board be established by July to oversee the new treatments and patient processing.
The bill’s passing follows the formation of a psychedelic task force last year, which was established to study the feasibility of psychedelic-assisted therapy and make recommendations on whether it should be permitted in the state. It handed in its findings and recommendations this January.